Zero-Valent Iron treatment of DNAPL
ARS recently completed a project in which treatability studies were performed using groundwater containing a TCE concentration of 362,000 µg/l and soil containing a TCE concentration of 290,400 µg/kg. A 52-day laboratory test was created to evaluate the effectiveness of FEROXSM powder to treat the high levels of high contaminant. Following the 52 days of treatment, 99% reduction of TCE in the batch reactors was observed. The results showed that the reduction of TCE approximates a first-order kinetic rate at the tested iron-to-TCE ratios. The study also demonstrated the dependence of reaction kinetics on iron dosage. Accordingly, higher dosages of FEROXSM resulted in a more rapid rate of TCE reduction. In addition, the higher iron dosages were more effective at controlling the accumulation of daughter products (ie. cis-1, 2-DCE) associated with the reduction of TCE. In summary, the data from this test confirmed FEROXSM successfully treats DNAPL-level concentrations of organic chemicals.
CONTENTS
  1. ARS obtains Exclusive License for Pneumatic Fracturing Patent
  2. Zero-Valent Iron treatment of DNAPL
  3. ARS Key Sponsor and Presenter at Oxidation and Reduction Conference
  4. Wetland Sediment Pb Reduction and Immobilization Study
  5. FEROXSM Biological Update Microbiological Effect of using Zero-Valent Iron Powder
  6. ARS completes First Project in Europe
  7. FEROXSM TCE Reduction - Oklahoma Facility
  8. FEROXSM Treatment of Freon-113
  9. Determining ZVI Emplacement using Magnetic Separation
  10. ARS Major Projects Coming to a Site Near You